You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

80 search results for: quality of life

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview (Copy)
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview (Copy)

Dermatology
Watch ADVENT now: Dermatologist Mark Koh describes the Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more
Type 2 Inflammation as the Common Thread in Multiple Diseases
videoanimation

Type 2 Inflammation as the Common Thread in Multiple Diseases

Type 2 Inflammation
This video highlights type 2 inflammation as the common thread that links AD, asthma, CRSwNP, and EoE.
View more
CRSwNP: A Chronic Type 2 Inflammatory Disease
expert video

CRSwNP: A Chronic Type 2 Inflammatory Disease

Rhinology
Prof. Peter Hellings describes how type 2 inflammation drives CRSwNP.
View more
Partnering With Patients for Clinical Decision-Making in CRSwNP
expert video

Partnering With Patients for Clinical Decision-Making in CRSwNP

Rhinology
Profs. Wytske Fokkens and Joaquim Mullol investigate the importance of partnering with patients with CRSwNP in clinical decision-making.
View more
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?

Rhinology
This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.
View more
What Do We Know About Type 2 Inflammation in COPD?
expert video

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology
Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.
View more
Targeting Type 2 Inflammation: ​Skin Barrier Normalization​
expert video

Targeting Type 2 Inflammation: ​Skin Barrier Normalization​

Dermatology
Highlights from ESPD 2023 ADVENT: Uncovering how type 2 inflammation influences skin barrier dysfunction in atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region